These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Circulating nucleosomes as a potential cancer biomarker in dogs with splenic nodular lesions. Meazzi S, Martini V, Marconato L, Aralla M, Licenziato L, Olimpo M, Roccabianca P, Sabattini S, Ubiali A, Zaccone R, Aresu L. Vet Q; 2024 Dec; 44(1):1-7. PubMed ID: 39224020 [Abstract] [Full Text] [Related]
26. ASSOCIATIONS BETWEEN DUAL-PHASE COMPUTED TOMOGRAPHY FEATURES AND HISTOPATHOLOGIC DIAGNOSES IN 52 DOGS WITH HEPATIC OR SPLENIC MASSES. Jones ID, Lamb CR, Drees R, Priestnall SL, Mantis P. Vet Radiol Ultrasound; 2016 Dec; 57(2):144-53. PubMed ID: 26763951 [Abstract] [Full Text] [Related]
27. Comparison between malignant and nonmalignant splenic masses in dogs using contrast-enhanced computed tomography. Fife WD, Samii VF, Drost WT, Mattoon JS, Hoshaw-Woodard S. Vet Radiol Ultrasound; 2004 Dec; 45(4):289-97. PubMed ID: 15373250 [Abstract] [Full Text] [Related]
30. Cytology of the spleen. Christopher MM. Vet Clin North Am Small Anim Pract; 2003 Jan; 33(1):135-52. PubMed ID: 12512380 [Abstract] [Full Text] [Related]
34. Canine splenic hemangiosarcoma with abdominal dissemination. Zhao D, Yamaguchi R, Tateyama S, Ogawa H, Yamazaki Y. J Vet Med Sci; 1994 Aug 05; 56(4):753-5. PubMed ID: 7999902 [Abstract] [Full Text] [Related]
35. Mass-to-splenic volume ratio and splenic weight as a percentage of body weight in dogs with malignant and benign splenic masses: 65 cases (2007-2008). Mallinckrodt MJ, Gottfried SD. J Am Vet Med Assoc; 2011 Nov 15; 239(10):1325-7. PubMed ID: 22044329 [Abstract] [Full Text] [Related]
36. Canine Non-Angiogenic, Non-Myogenic Splenic Stromal Sarcoma: a Retrospective Clinicopathological Analysis and Investigation of Podoplanin as a Marker of Tumour Histogenesis. Wittenberns BM, Thamm DH, Palmer EP, Regan DP. J Comp Pathol; 2021 Oct 15; 188():1-12. PubMed ID: 34686271 [Abstract] [Full Text] [Related]
39. Gadoxetate disodium (Gd-EOB-DTPA) contrast-enhanced magnetic resonance imaging for differentiation between benign and malignant splenic lesions in dogs. Lux CN, Sula MM, Sun X, Hecht S. Vet Radiol Ultrasound; 2024 Sep 15; 65(5):556-566. PubMed ID: 38899373 [Abstract] [Full Text] [Related]
40. Prospective observational study of dogs with splenic mass rupture suggests potentially lower risk of malignancy and more favourable perioperative outcomes. Stewart SD, Ehrhart EJ, Davies R, Khanna C. Vet Comp Oncol; 2020 Dec 15; 18(4):811-817. PubMed ID: 32458544 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]